VivoSim Labs, INC. — Form 8-K
Filed October 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
VivoSim Labs amended and restated its 2022 Equity Incentive Plan effective September 30, 2026. The plan authorizes up to 3,415,978 shares for grant, plus recycled shares from the prior 2012 plan (up to 1,367,722 shares). Full-value awards (RSUs, restricted stock) count as 1.15 shares per grant against the reserve. The plan permits options, restricted stock, RSUs, stock appreciation rights, and performance awards to employees, directors, and consultants. No material dollar amounts, grant specifics, or vesting changes are disclosed in this form—it is a restated plan document establishing administrative framework.
Why this rating
Plan restatement is administrative. Share authorization (3.4M) is ~45% of current market cap, but typical for small-cap equity programs. No new grants, vesting acceleration, or material changes disclosed here—routine governance document.
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.